|
Volumn 153, Issue 2, 2007, Pages 213-223
|
Highlights from the 20th Scientific Sessions of the American Heart Association: November 12 to 15, 2006, Chicago, Illinois
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;
ANTICOAGULANT AGENT;
ANTIDOTE;
APTAMER;
ATRIAL NATRIURETIC FACTOR ALPHA;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FOLIC ACID;
GLIMEPIRIDE;
NICORANDIL;
PACLITAXEL;
PEXELIZUMAB;
PIOGLITAZONE;
RB 006;
RB 007;
REG1;
STATINE DERIVATIVE;
UNCLASSIFIED DRUG;
VITAMIN B GROUP;
ACUTE HEART FAILURE;
ACUTE HEART INFARCTION;
ARTERY INTIMA PROLIFERATION;
BLEEDING;
BRAIN DISEASE;
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTINUOUS INFUSION;
CORONARY ARTERY BYPASS GRAFT;
DEFIBRILLATOR;
DRUG DOSE ESCALATION;
DRUG ELUTING STENT;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION SIZE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE PERFUSION;
HOSPITALIZATION;
HUMAN;
IN-STENT RESTENOSIS;
LENGTH OF STAY;
META ANALYSIS;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
ST SEGMENT ELEVATION;
SYSTEMATIC REVIEW;
TRANSTHORACIC ECHOCARDIOGRAPHY;
TREATMENT INDICATION;
|
EID: 33846264065
PISSN: 00028703
EISSN: 10976744
Source Type: Journal
DOI: 10.1016/j.ahj.2006.12.001 Document Type: Review |
Times cited : (2)
|
References (0)
|